Differences in asthma study models and the effectiveness of β2 -adrenoceptor ligands: response to Lipworth et al

Br J Pharmacol. 2016 Jan;173(1):250-1. doi: 10.1111/bph.13334.

Authors

Richard A Bond¹, Vaidehi J Thanawala^{1

2}, Sergio Parra³, Paul Leff⁴

Affiliations

¹ Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, TX, USA.
² Department of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, Houston, TX, USA.
³ Vapogenix Inc., Houston, TX, USA.
⁴ Consultant in Pharmacology, Cheshire, UK.

No abstract available

Publication types

Comment

MeSH terms

Adrenergic beta-Antagonists / pharmacology*
Animals
Asthma*
Female
Male

Substances

Adrenergic beta-Antagonists